478 results on '"Kragballe, Knud"'
Search Results
2. Role of eicosanoids in psoriasis and atopic skin diseases
3. Arachidonic acid metabolism in skin
4. CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways
5. Unmet needs in the treatment of psoriasis
6. National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines
7. Treatment of plaque psoriasis
8. Atopic Dermatitis and Risk of Skin Cancer: A Danish Nationwide Cohort Study (1977–2006)
9. Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis
10. Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin
11. 1α,25(OH)2D3 regulates NF-κB DNA binding activity in cultured normal human keratinocytes through an increase in IκBα expression
12. Growth medium-dependent ERK1/2 and AP-1 activity in cultured normal human keratinocytes modulates 1α,25-dihydroxyvitamin D3-induced differentiation
13. Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity
14. Management of Difficult to Treat Locations of Psoriasis
15. Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis
16. The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice
17. Juvenile Psoriasis und ihre Behandlungsmöglichkeiten: Konsensus einer europäischen Expertengruppe
18. Juvenile psoriasis and its clinical management: a European expert group consensus
19. Adalimumab plus topical treatment (calcipotriol/betamethasone) in the treatment of moderate to severe psoriasis: Response across subgroups in BELIEVE: P3342
20. MK2 regulates the early stages of skin tumor promotion
21. Immunosuppressive therapy in dermatology and PML
22. Immunsuppression in der Dermatologie und PML
23. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes
24. Enkephalin-like immunoreactivity in human skin is found selectively in a fraction of CD68 – positive dermal cells: increase in enkephalin-positive cells in lesional psoriasis
25. Signal Transduction Pathways in the Skin
26. Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases
27. LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin: Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin
28. Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in Denmark
29. Mitogen- and Stress-Activated Protein Kinase 1 Is Activated in Lesional Psoriatic Epidermis and Regulates the Expression of Pro-Inflammatory Cytokines
30. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment
31. Long-term efficacy of a calcipotriene/betamethasone dipropionate two-compound product in Psoriasis vulgaris: P2891
32. A pooled analysis of studies with a calcipotriene/betamethasone two-compound product in severe Psoriasis vulgaris: P2852
33. Inverse Regulation of the Nuclear Factor-κB Binding to the p53 and Interleukin-8 κB Response Elements in Lesional Psoriatic Skin
34. A 1-YEAR SAFETY STUDY OF REPEATED COURSES OF A CALCIPOTRIENE/BETAMETHASONE TWO-COMPOUND PRODUCT IN PSORIASIS VULGARIS: P2704
35. KID Syndrome: Report of a Scandinavian Patient with Connexin-26 Gene Mutation
36. Pharmacokinetics and Therapeutic Efficacy of Retinoids in Skin Diseases
37. Lysophosphatidylcholine Induces Keratinocyte Differentiation and Upregulation of AP-1- and NF-κB DNA-binding Activity
38. Supplementation with evening primrose oil in atopic dermatitis: Effect on fatty acids in neutrophils and epidermis
39. Epidermal Overexpression of Interleukin-19 and -20 mRNA in Psoriatic Skin Disappears After Short-Term Treatment with Cyclosporine A or Calcipotriol
40. Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin
41. HuMax-CD4: A Fully Human Monoclonal Anti-CD4 Antibody for the Treatment of Psoriasis Vulgaris
42. 1α,25-Dihydroxyvitamin D3 Stimulates Activator Protein 1 DNA-Binding Activity by a Phosphatidylinositol 3-Kinase/Ras/MEK/Extracellular Signal Regulated Kinase 1/2 and c-Jun N-Terminal Kinase 1-Dependent Increase in c-Fos, Fra1, and c-Jun Expression in Human Keratinocytes
43. Modulation of Keratinocyte Gene Expression and Differentiation by PPAR-Selective Ligands and Tetradecylthioacetic Acid
44. 1α,25-Dihydroxyvitamin D3 Induced Differentiation of Cultured Human Keratinocytes is Accompanied by a PKC-Independent Regulation of AP-1 DNA Binding Activity
45. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
46. Vitamin D3 analogues
47. Caring for young people with moderate to severe psoriasis: an interpretive description of parental perspectives
48. Proliferation and Differentiation of Cultured Human Keratinocytes is Modulated by 1,25(OH)2D3 and Synthetic Vitamin D3 Analogues in a Cell Density-, Calcium- and Serum-Dependent Manner*
49. Efficacy, Tolerability, and Safety of Calcipotriol Ointment in Disorders of Keratinization: Results of a Randomized, Double-blind, Vehicle-Controlled, Right/Left Comparative Study
50. Reduced Neutrophil LTB4 Release in Atopic Dermatitis Patients Despite Normal Fatty Acid Composition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.